Your browser doesn't support javascript.
loading
Low-intensity transcranial focused ultrasound suppresses pain by modulating pain processing brain circuits.
Kim, Min Gon; Yu, Kai; Yeh, Chih-Yu; Fouda, Raghda; Argueta, Donovan Alexander; Kiven, Stacy B; Ni, Yunruo; Niu, Xiaodan; Chen, Qiyang; Kim, Kang; Gupta, Kalpna; He, Bin.
Affiliation
  • Kim MG; Carnegie Mellon University, Pittsburgh, Pennsylvania, United States.
  • Yu K; Carnegie Mellon University, Pittsburgh, Pennsylvania, United States.
  • Yeh CY; Carnegie Mellon University, Pittsburgh, Pennsylvania, United States.
  • Fouda R; University of California, Irvine, Orange, California, United States.
  • Argueta DA; University of California, Irvine, Orange, California, United States.
  • Kiven SB; University of California, Irvine, Orange, California, United States.
  • Ni Y; Carnegie Mellon University, Pittsburgh, Pennsylvania, United States.
  • Niu X; Carnegie Mellon University, Pittsburgh, Pennsylvania, United States.
  • Chen Q; University of Pittsburgh, Pittsburgh, Pennsylvania, United States.
  • Kim K; University of Pittsburgh, Pittsburgh, Pennsylvania, United States.
  • Gupta K; University of California, Irvine Medical Center, Orange, California, United States.
  • He B; Carnegie Mellon University, Pittsburgh, Pennsylvania, United States.
Blood ; 2024 Jul 08.
Article in En | MEDLINE | ID: mdl-38976875
ABSTRACT
There is an urgent and unmet clinical need to develop non-pharmacological interventions for chronic pain management due to the critical side effects of opioids. Low-intensity transcranial focused ultrasound is an emerging non-invasive neuromodulation technology with high spatial specificity and deep brain penetration. Here, we developed a tightly-focused 128-element ultrasound transducer to specifically target small mouse brains, employing dynamic focus steering. We demonstrate that transcranial focused ultrasound stimulation at pain processing brain circuits can significantly alter pain-associated behaviors in mouse models in vivo. Our findings indicate that a single-session focused ultrasound stimulation to the primary somatosensory cortex (S1) significantly attenuates heat pain sensitivity in wild-type mice and modulates heat and mechanical hyperalgesia in a humanized mouse model of chronic pain in sickle cell disease. Results further revealed a sustained behavioral change associated with heat hypersensitivity by targeting deeper cortical structures (e.g., insula) and multi-session focused ultrasound stimulation to S1 and insula. Analyses of brain electrical rhythms through electroencephalography demonstrated a significant change in noxious heat hypersensitive- and chronic hyperalgesia-associated neural signals following focused ultrasound treatment. Validation of efficacy was carried out through control experiments, tuning ultrasound parameters, adjusting inter-experiment intervals, and investigating effects on age, gender, genotype, and in a head-fixed awake model. Importantly, transcranial focused ultrasound was found to be safe, causing no adverse effects on motor function and brain's neuropathology. In conclusion, the validated proof of principle experimental evidence demonstrates the translational potential of novel focused ultrasound neuromodulation for next-generation pain treatment without adverse effects.

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Blood Year: 2024 Document type: Article Affiliation country: Estados Unidos Publication country: EEUU / ESTADOS UNIDOS / ESTADOS UNIDOS DA AMERICA / EUA / UNITED STATES / UNITED STATES OF AMERICA / US / USA

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Blood Year: 2024 Document type: Article Affiliation country: Estados Unidos Publication country: EEUU / ESTADOS UNIDOS / ESTADOS UNIDOS DA AMERICA / EUA / UNITED STATES / UNITED STATES OF AMERICA / US / USA